Director of the Theoretical Chemistry Laboratory (Sorbonne University/CNRS)
Jean-Philip Piquemal is the Director of the Theoretical Chemistry Laboratory (Sorbonne University/CNRS) and specializes in the modeling of biological systems applied to pharmacy and medicine. With the start-up Qubit Pharmaceuticals, which he launched in 2021, this hard science enthusiast is pursuing the dual objective of accelerating the discovery of new drugs and decompartmentalizing scientific research.
For a science from outside of the box. Located at the crossroads of physics, chemistry and computer science, Jean-Philip Piquemal is not a researcher cloistered in his laboratory. While he has been heading the Laboratory of Theoretical Chemistry (LCT) since 2019, a joint unit supported by Sorbonne University and the CNRS, he set up his own company, Qubit Pharmarceuticals, in 2020, with which he intends to revolutionize the design of new drugs using super-powerful computers, and also to build bridges between academia and industry. He launched this start-up with four other scientists, including chemist Louis Lagardère, also a researcher at Sorbonne University, with the goal of accelerating the discovery of new drugs. "The goal is to treat people," insists Jean-Philip Piquemal. "We are trying to find outlets for our PhD students and also to test the technology we were developing at the LCT on a large scale.
